La Tribune highlights our biotech company GEG-Tech, whose research laboratory is located in Saclay.
The article notably reveals a technological partnership with Servier, France’s second-largest pharmaceutical group. GEG-Tech, a specialist in genetic engineering, is implementing its technology to strengthen the company’s drug screening and therapeutic innovation. The company announced an acceleration of its growth earlier this year. This is a fine example of technological collaboration at Paris-Saclay, based on the “open innovation” model.
You can read this article (in french) by follow the link below
https://www.latribune.fr/technos-medias/innovation-et-start-up/a-saclay-l-incubateur-de-pointe-de-servier-cherche-a-attirer-les-start-up-1019851.html
